NUTX - Nutex Health, Inc. Stock Price, Fair Value and News

0.66USD+0.01 (+1.54%)Market Closed

Market Summary

USD0.66+0.01

Market Closed

1.54%

NUTX Stock Price

View Fullscreen

NUTX RSI Chart

NUTX Valuation

Market Cap

32.8M

Price/Earnings (Trailing)

-0.68

Price/Sales (Trailing)

0.13

EV/EBITDA

-2.55

Price/Free Cashflow

26.1

NUTX Price/Sales (Trailing)

NUTX Profitability

Operating Margin

92.91%

EBT Margin

-19.58%

Return on Equity

-78.68%

Return on Assets

-12.14%

Free Cashflow Yield

3.83%

NUTX Fundamentals

NUTX Revenue

Revenue (TTM)

247.6M

Rev. Growth (Yr)

29.68%

Rev. Growth (Qtr)

11.07%

NUTX Earnings

Earnings (TTM)

-48.3M

Earnings Growth (Yr)

-114.33%

Earnings Growth (Qtr)

-470.47%

Breaking Down NUTX Revenue

Last 7 days

-5.7%

Last 30 days

-56.9%

Last 90 days

-68.0%

Trailing 12 Months

-92%

How does NUTX drawdown profile look like?

NUTX Financial Health

Current Ratio

1.56

Debt/Equity

0.43

Debt/Cashflow

0.05

NUTX Investor Care

Shares Dilution (1Y)

14.34%

Diluted EPS (TTM)

-1.2

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	196.5M	197.4M	231.7M	247.6M
2022	323.3M	318.5M	229.0M	219.3M
2021	288.4M	302.8M	317.2M	331.5M
2020	69.5M	137.7M	205.9M	274.0M
2019	1.6M	2.0M	1.7M	1.4M
2018	359.1K	695.1K	1.0M	1.4M
2017	216.7K	152.2K	87.7K	23.2K
2016	410.2K	345.7K	281.2K	0
2015	1.1M	1.2M	1.2M	474.7K
2014	1.3M	1.2M	1.1M	1.1M
2013	1.5M	1.5M	1.4M	1.5M
2012	1.9M	1.8M	1.8M	1.6M
2011	1.1M	1.3M	1.6M	1.8M
2010	0	0	0	874.8K

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Nutex Health, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 12, 2024	montgomery pamela w.	acquired	-	-	16,502	chief legal officer
Mar 12, 2024	bates jon christian	acquired	-	-	49,505	chief financial officer
Nov 20, 2023	vo thomas t.	bought	62,195	0.226	275,200	chief executive officer
Nov 17, 2023	vo thomas t.	bought	51,704	0.23	224,800	chief executive officer
Nov 15, 2023	detillio joshua	bought	34,174	0.2441	140,000	chief operating officer
Sep 22, 2023	hosseinion warren	gifted	-	-	-141,000	president
Aug 31, 2023	vo thomas t.	bought	42,651	0.28	152,326	chief executive officer
Aug 30, 2023	vo thomas t.	bought	94,843	0.31	305,947	chief executive officer
Aug 29, 2023	vo thomas t.	bought	102,823	0.3	342,744	chief executive officer
Aug 28, 2023	vo thomas t.	bought	55,715	0.28	198,983	chief executive officer

Which funds bought or sold NUTX recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 24, 2024	GDS Wealth Management	unchanged	-	-93,355	106,454	0.01%
Apr 24, 2024	IAG Wealth Partners, LLC	unchanged	-	-1,261	1,439	-%
Apr 23, 2024	Global Retirement Partners, LLC	unchanged	-	-	-	-%
Apr 18, 2024	Capital Advisors, Ltd. LLC	new	-	-	-	-%
Apr 15, 2024	Wealthcare Advisory Partners LLC	new	-	1,271	1,271	-%
Apr 15, 2024	Sunbelt Securities, Inc.	sold off	-100	-54.00	-	-%
Apr 15, 2024	Sunbelt Securities, Inc.	new	-	29.00	29.00	-%
Apr 15, 2024	WEALTH ENHANCEMENT ADVISORY SERVICES, LLC	added	53.8	-423	1,919	-%
Apr 12, 2024	DLK Investment Management, LLC	added	109	379	3,673	-%
Apr 10, 2024	ONE PLUS ONE WEALTH MANAGEMENT, LLC	added	958	417,668	507,668	0.29%

Are Funds Buying or Selling NUTX?

Are funds buying NUTX calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own NUTX

No. of Funds

Unveiling Nutex Health, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Sep 26, 2023	premier macy management holdings, llc	4.99%	33,046,116	SC 13G/A
Jul 07, 2023	premier macy management holdings, llc	320%	41,494,039	SC 13G

Recent SEC filings of Nutex Health, Inc.

View All Filings

Date Filed	Form Type	Document
Apr 26, 2024	PRE 14A	PRE 14A
Apr 12, 2024	3	Insider Trading
Apr 11, 2024	8-K	Current Report
Apr 08, 2024	8-K	Current Report
Apr 08, 2024	3	Insider Trading
Mar 29, 2024	10-K	Annual Report
Mar 28, 2024	8-K	Current Report
Mar 15, 2024	NT 10-K	NT 10-K
Mar 14, 2024	4	Insider Trading
Mar 14, 2024	4	Insider Trading

Nutex Health, Inc. News

Latest updates

Nutex Health, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	11.1%	69,669	62,723	58,924	56,329	53,724	28,395	58,048	79,127	63,402	117,972	62,815	47,206	31,597	15,988	379	466	459	452	445	212	1,336
Cost Of Revenue	-	-	-	-	-	-	-	-	4,493	4,491	4,381	4,188	1,587	235	211	265	199	252	83.00	327	168	484
Gross Profit	87.0%	13,213	7,066	9,647	4,848	530	-23,712	6,638	35,815	46,597	76,008	29,137	427	157,087	139	114	267	263	111	118	44.00	853
Costs and Expenses	1.4%	56,456	55,657	49,278	51,482	57,043	52,108	51,410	43,312	43,916	41,963	33,677	-	-	-	-	-	-	-	-	-	-
Operating Expenses	399.0%	39,358	7,887	10,009	9,293	6,309	404,968	8,016	6,577	2,654	1,546	1,533	4,577	5,395	-1,636	-531	1,206	3,843	1,017	1,604	970	425
S&GA Expenses	9.0%	8,500	7,795	9,760	7,176	6,309	6,752	4,077	6,577	-824	1,546	1,533	4,426	2,558	699	53.00	121	-1,160	707	95.00	67.00	-544
R&D Expenses	-	-	-	-	-	-	-	-	74.00	77.00	72.00	60.00	77.00	54.00	74.00	314	115	197	108	282	181	-
EBITDA Margin	-403.8%	-0.06*	0.02*	-2.14*	-2.16*	-1.80*	-1.51*	0.49*	0.58*	0.46*	0.83*	0.62*	0.54*	0.58*	-	-	-	-	-	-	-	-
Interest Expenses	3.4%	4,237	4,098	4,843	3,140	2,862	3,403	4,370	1,856	2,682	1,260	1,505	11.00	6,100	18.00	249	65.00	44.00	48.00	15.00	42.00	-205
Income Taxes	-776.1%	-2,998	-342	-815	-910	1,805	-8,543	19,653	176	-47.82	454	482	-	-	-	-	-	-	-	-	-	-
Earnings Before Taxes	-531.1%	-30,709	-4,866	-5,082	-7,832	-8,853	-431,452	-4,344	25,002	41,108	74,948	30,160	-4,484	144,839	1,756	227	-1,004	-3,660	-857	-1,630	-968	-
EBT Margin	-70.3%	-0.20*	-0.11*	-2.30*	-2.30*	-1.91*	-1.61*	0.43*	0.53*	0.43*	0.77*	0.57*	0.49*	0.53*	-	-	-	-	-	-	-	-
Net Income	-470.5%	-31,617	-5,542	-4,266	-6,921	-14,752	-412,186	-23,998	24,826	-22,457	74,494	29,678	50,879	105,109	1,756	227	-1,122	-3,660	-857	-1,630	-968	995
Net Income Margin	-43.7%	-0.20*	-0.14*	-2.22*	-2.33*	-1.94*	-1.89*	0.17*	0.33*	0.40*	0.82*	0.62*	0.55*	0.39*	-	-	-	-	-	-	-	-
Free Cashflow	54.7%	-1,776	-3,922	-5,878	-4,838	-1,384	-13,192	1,041	35,740	42,933	20,762	81,607	-567	88,230	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-17.0%	398	480	436	430	432	432	872	83.00	395	83.00	77.00	76.00	41.00	7.00	7.00	6.00	7.00	2.00	2.00	2.00	0.00
Current Assets	1.1%	91.00	90.00	92.00	89.00	98.00	108	149	15.00	154	12.00	6.00	4.00	0.00	0.00	0.00	0.00	1.00	0.00	0.00	0.00	0.00
Cash Equivalents	-18.0%	22.00	27.00	33.00	33.00	34.00	37.00	48.00	13.00	36.00	34.00	38.00	4.00	26.00	0.00	0.00	0.00	1.00	0.00	1.00	1.00	0.00
Inventory	26.4%	3.00	3.00	2.00	3.00	4.00	3.00	3.00	-	3.00	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	-
Net PPE	-4.8%	81.00	85.00	83.00	8.00	82.00	72.00	10.00	0.00	152	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Goodwill	-4.7%	17.00	18.00	17.00	17.00	17.00	17.00	425	58.00	1.00	55.00	55.00	55.00	-	-	-	3.00	3.00	-	-	-	-
Liabilities	-14.8%	319	375	328	320	311	302	70.00	136	203	9.00	10.00	10.00	1.00	2.00	4.00	4.00	5.00	1.00	1.00	1.00	2.00
Current Liabilities	-13.3%	58.00	67.00	57.00	48.00	55.00	44.00	56.00	8.00	38.00	7.00	7.00	7.00	1.00	1.00	4.00	4.00	5.00	-	-	-	1.00
Long Term Debt	36.3%	26.00	19.00	25.00	25.00	23.00	25.00	16.00	-	79.00	-	-	-	-	-	-	-	-	-	-	0.00	0.00
LT Debt, Current	-45.0%	11.00	20.00	16.00	10.00	13.00	4.00	8.00	4.00	10.00	2.00	2.00	1.00	-	-	2.00	2.00	2.00	-	-	-	0.00
LT Debt, Non Current	36.3%	26.00	19.00	25.00	25.00	23.00	25.00	16.00	-	79.00	-	-	-	-	-	-	-	-	-	-	-	-
Shareholder's Equity	-31.7%	61.00	90.00	108	110	96.00	133	556	187	192	213	161	164	147	5.00	3.00	2.00	51.00	4.00	5.00	5.00	1.00
Retained Earnings	-8.4%	-409	-377	-371	-368	-363	-358	58.00	-48.65	102	-27.31	-25.40	-22.66	-18.22	-11.71	-13.46	-13.69	-12.57	-13.97	-13.59	-13.02	-5.45
Additional Paid-In Capital	0.7%	470	467	464	460	458	469	467	121	12.00	101	93.00	89.00	17.00	17.00	17.00	15.00	14.00	16.00	15.00	15.00	4.00
Shares Outstanding	0.9%	45.00	45.00	44.00	43.00	43.00	43.00	43.00	-	40.00	-	40.00	3.00	0.00	-	-	-	-	-	-	-	-
Minority Interest	17.9%	18.00	15.00	16.00	4.00	24.00	22.00	31.00	0.00	77.00	0.00	-0.09	-0.04	-	-	-	-	-	-	-	-	-
Float	-	-	-	145	-	-	-	1,034	-	-	-	86.00	-	-	-	5.00	-	-	-	2.00	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	-190.2%	-1,776	1,968	12.00	1,052	4,506	-7,301	17,662	35,741	46,424	24,254	103,322	-567	88,230	-189	-495	-872	-1,490	-861	-823	-864	233
Share Based Compensation	-	-	-	-	-	54.00	81.00	-14,142	14,197	4,027	-	-3,852	3,853	-	305	1,418	849	-259	168	503	39.00	67.00
Cashflow From Investing	123.9%	866	-3,619	-3,069	-5,416	7,880	-5,890	2,265	-8,591	-11,769	-3,491	-25,603	3,888	-61,236	50.00	-	-2.66	-662	-24.81	-19.56	-41.74	-116
Cashflow From Financing	8.5%	-3,914	-4,276	2,975	2,945	-14,751	2,213	-7,884	-27,709	-32,774	-24,555	-68,915	393	-8,445	104	391	-22.05	3,090	187	231	2,227	-1.93
Buy Backs	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.00	1.00	-	-	-144*	-	-

NUTX Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenue:
Total revenue	$ 247,646,316	$ 219,294,306	$ 331,531,311
Operating costs and expenses:
Payroll	108,377,938	111,785,110	93,523,438
Contract services	42,349,982	35,913,441	17,050,957
Medical supplies	14,151,140	12,118,893	12,514,367
Depreciation and amortization	17,591,572	13,131,374	7,662,464
Other	30,401,513	30,923,750	21,499,127
Total operating costs and expenses	212,872,145	203,872,568	152,250,353
Gross profit	34,774,171	15,421,738	179,280,958
Corporate and other costs:
Facilities closing costs	217,266
Acquisition costs	43,464	3,885,666	3,553,716
Stock-based compensation	2,835,971	189,581
Impairment of assets	29,082,203
Impairment of goodwill	1,139,297	398,135,038
General and administrative expenses	33,229,718	19,810,607	5,462,344
Total corporate and other costs	66,547,919	422,020,892	9,016,060
Operating income (loss)	(31,773,748)	(406,599,154)	170,264,898
Interest expense, net	16,317,869	12,490,260	6,196,026
Other expense (income)	399,182	559,299	(5,422,144)
Income (loss) before taxes	(48,490,799)	(419,648,713)	169,491,016
Income tax expense (benefit)	(5,067,084)	13,090,905	965,731
Net income (loss)	(43,423,715)	(432,739,618)	168,525,285
Less: net income (loss) attributable to noncontrolling interests	2,362,899	(7,959,172)	35,931,957
Net income (loss) attributable to Nutex Health Inc.	$ (45,786,614)	$ (424,780,446)	$ 132,593,328
Earnings (loss) per common share
Basic earnings (loss) per common share (in dollar per share)	$ (0.07)	$ (0.67)	$ 0.22
Diluted earnings (loss) perc common share (in dollar per share)	$ (0.07)	$ (0.67)	$ 0.22
Hospital division
Revenue:
Total revenue	$ 218,070,397	$ 198,508,245	$ 331,531,311
Population health management division
Revenue:
Total revenue	$ 29,575,919	$ 20,786,061

NUTX Balance Sheet

2023-12-31

CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 22,002,056	$ 34,255,264
Accounts receivable	58,624,301	57,777,386
Accounts receivable - related parties	4,152,068	538,183
Inventories	3,390,584	3,533,285
Prepaid expenses and other current assets	2,679,394	1,869,806
Total current assets	90,848,403	97,973,924
Property and equipment, net	81,387,649	82,094,352
Operating right-of-use assets	11,853,082	20,466,632
Financing right-of-use assets	176,146,329	192,591,624
Intangible assets, net	20,512,636	21,191,390
Goodwill, net	17,066,263	17,010,637
Other assets	431,135	423,426
Total assets	398,245,497	431,751,985
Current liabilities:
Accounts payable	18,899,196	23,614,387
Accounts payable - related parties	6,382,197	3,915,661
Lines of credit	3,371,676	2,623,479
Current portion of long-term debt	10,808,721	12,546,097
Operating lease liabilities, current portion	1,579,987	1,703,014
Financing lease liabilities, current portion	4,315,979	4,219,518
Accrued expenses and other current liabilities	12,955,296	6,240,813
Total current liabilities	58,313,052	54,862,969
Long-term debt, net	26,314,733	23,051,152
Operating lease liabilities, net	15,479,639	19,438,497
Financing lease liabilities, net	213,886,213	203,619,756
Deferred tax liabilities	5,145,754	10,452,211
Total liabilities	319,139,391	311,424,585
Commitments and contingencies
Equity:
Common stock, $0.001 par value; 950,000,000 shares authorized; 676,679,911 and 650,223,840 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively	676,680	650,224
Additional paid-in capital	469,849,049	458,498,402
Accumulated deficit	(409,072,539)	(363,285,925)
Nutex Health Inc. equity	61,453,190	95,862,701
Noncontrolling interests	17,652,916	24,464,699
Total equity	79,106,106	120,327,400
Total liabilities and equity	$ 398,245,497	$ 431,751,985

About Nutex Health, Inc.

Nutex Health Inc. operates as a network of micro-hospitals. It operates through three segments: Hospital, Population Health Management, and Real Estate. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. The Population Health Management segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment leases land and hospital building. It also provides healthcare and facility management services; and healthcare billing, coding, and collection services. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.

CEO	Dr. Thomas T. Vo M.B.A., M.D.
WEBSITE	nutexhealth.com
INDUSTRY	Healthcare Plans
EMPLOYEES	800

Nutex Health, Inc. Frequently Asked Questions

What is the ticker symbol for Nutex Health, Inc.? What does NUTX stand for in stocks?

NUTX is the stock ticker symbol of Nutex Health, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Nutex Health, Inc. (NUTX)?

As of Fri Apr 26 2024, market cap of Nutex Health, Inc. is 32.8 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NUTX stock?

You can check NUTX's fair value in chart for subscribers.

What is the fair value of NUTX stock?

You can check NUTX's fair value in chart for subscribers. The fair value of Nutex Health, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Nutex Health, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NUTX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Nutex Health, Inc. a good stock to buy?

The fair value guage provides a quick view whether NUTX is over valued or under valued. Whether Nutex Health, Inc. is cheap or expensive depends on the assumptions which impact Nutex Health, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NUTX.

What is Nutex Health, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 26 2024, NUTX's PE ratio (Price to Earnings) is -0.68 and Price to Sales (PS) ratio is 0.13. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NUTX PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Nutex Health, Inc.'s stock?

In the past 10 years, Nutex Health, Inc. has provided -0.12 (multiply by 100 for percentage) rate of return.